
$158,000 price tag for new ALS drug reignites anger at Big Pharma
Fox News
A new drug that slows the progression of ALS is exorbitantly expensive, one again raising anger at the pharmaceutical industry for locking life-changing drugs behind high costs.
As a result, getting on a drug that slows progression quickly is vital to many patients, but the high price tag set by Amylyx causes insurance companies to lock the drug behind a lengthy application process, and the drug is sometimes cost-prohibitive for patients even with coverage, according to the Associated Press. Anders Hagstrom is a reporter with Fox News Digital covering national politics and major breaking news events. Send tips to Anders.Hagstrom@Fox.com, or on Twitter: @Hagstrom_Anders.
"When someone’s lifespan is measured in months, making people go through these multiple rounds of review is just cruel," said Neil Thakur, the chief mission officer at the ALS Association.













